Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongping Song

Showing results (11-20 of 252) with videos related to

Pageof 26
Sort By:
Biomarker Research|September 19, 2019
Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemiaJuanjuan Zhao, Yongping Song, Delong Liu
Journal of Hematology & Oncology|May 7, 2020
How to select IgG subclasses in developing anti-tumor therapeutic antibodiesJifeng Yu, Yongping Song, Wenzhi Tian
Frontiers in Immunology|September 5, 2022
Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemiaYanyan Liu, Yongping Song, Qingsong Yin
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2019
Individual prediction of lateral neck metastasis risk in patients with unifocal papillary thyroid carcinomaHu Hei, Yongping Song, Jianwu Qin
Oncology Letters|December 2, 2015
Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature reviewYong Zhang, Yongping Song, Quanli Gao
Journal of Hematology & Oncology|July 6, 2019
Engineering switchable and programmable universal CARs for CAR T therapyDelong Liu, Juanjuan Zhao, Yongping Song
Biochemical and Biophysical Research Communications|December 13, 2017
Short-term culture with IL-2 is beneficial for potent memory chimeric antigen receptor T cell productionXuhua Zhang, Xiaodong Lv, Yongping Song
Journal of Hematology & Oncology|February 16, 2019
Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemiaJuanjuan Zhao, Yongping Song, Delong Liu
Cancer Letters|November 15, 2016
EAI045: The fourth-generation EGFR inhibitor overcoming T790M and C797S resistanceShuhang Wang, Yongping Song, Delong Liu
Journal of Hematology & Oncology|March 17, 2018
CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficaciesLi-Na Zhang, Yongping Song, Delong Liu
Pageof 26

Showing results (11-20 of 252) with videos related to

Sort By:
Pageof 26
Biomarker Research|September 19, 2019
Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemiaJuanjuan Zhao, Yongping Song, Delong Liu
Journal of Hematology & Oncology|May 7, 2020
How to select IgG subclasses in developing anti-tumor therapeutic antibodiesJifeng Yu, Yongping Song, Wenzhi Tian
Frontiers in Immunology|September 5, 2022
Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemiaYanyan Liu, Yongping Song, Qingsong Yin
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2019
Individual prediction of lateral neck metastasis risk in patients with unifocal papillary thyroid carcinomaHu Hei, Yongping Song, Jianwu Qin
Oncology Letters|December 2, 2015
Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature reviewYong Zhang, Yongping Song, Quanli Gao
Journal of Hematology & Oncology|July 6, 2019
Engineering switchable and programmable universal CARs for CAR T therapyDelong Liu, Juanjuan Zhao, Yongping Song
Biochemical and Biophysical Research Communications|December 13, 2017
Short-term culture with IL-2 is beneficial for potent memory chimeric antigen receptor T cell productionXuhua Zhang, Xiaodong Lv, Yongping Song
Journal of Hematology & Oncology|February 16, 2019
Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemiaJuanjuan Zhao, Yongping Song, Delong Liu
Cancer Letters|November 15, 2016
EAI045: The fourth-generation EGFR inhibitor overcoming T790M and C797S resistanceShuhang Wang, Yongping Song, Delong Liu
Journal of Hematology & Oncology|March 17, 2018
CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficaciesLi-Na Zhang, Yongping Song, Delong Liu
Pageof 26